<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04086381</url>
  </required_header>
  <id_info>
    <org_study_id>NL64709.068.18</org_study_id>
    <nct_id>NCT04086381</nct_id>
  </id_info>
  <brief_title>Creatine Effect on Brown Adipose Tissue Activation</brief_title>
  <acronym>CreaBAT</acronym>
  <official_title>Creatine Monohydrate Supplementation in Young, Healthy Vegetarian Adults and Its Effect on Brown Adipose Tissue Activation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pre-clinical studies indicate that creatine may play a substantial role in diet-induced&#xD;
      thermogenesis and may have a profound effect on energy balance. A recent retrospective study&#xD;
      of BAT activation on PET-CT scans in humans showed a positive association with the estimated&#xD;
      renal creatinine clearance and BAT activation, possibly linking creatine metabolism in humans&#xD;
      to BAT activity. In humans, so far little options are available to activate brown adipose&#xD;
      tissue. The most potent intervention to activate BAT is via cold, which has previously been&#xD;
      shown to have metabolic effects in humans. Provided the potential health benefits of brown&#xD;
      adipose tissue activation in humans, and provided the role of brown fat in diet induced&#xD;
      thermogenesis, we here aim to determine whether creatine monohydrate supplementation can&#xD;
      increase diet-induced thermogenesis and activate brown adipose tissue in humans.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Actual">January 22, 2020</completion_date>
  <primary_completion_date type="Actual">January 22, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>A double-blind, randomised, controlled, cross-over intervention trial.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brown adipose tissue activation through 18F-FDG PET-MRI</measure>
    <time_frame>Day 10 of protocol</time_frame>
    <description>Standard Uptake Value (SUV)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diet-induced thermogenesis through indirect calorimetry</measure>
    <time_frame>Day 8 of protocol</time_frame>
    <description>Whole body energy expenditure in kJ/kg/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Posphocreatine (PCr) Recovery through 31P-MRS</measure>
    <time_frame>Day 9 of protocol</time_frame>
    <description>Halftime of PCr Recovery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Diet-induced Thermogenesis</condition>
  <condition>Brown Adipose Tissue Activation</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral injestion of 20 grams of creatine monohydrate daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral injestion of 20 grams of cellulose daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Creatine monohydrate</intervention_name>
    <description>5 grams of creatine monohydrate, four times daily, for 9 consecutive days.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo cellulose</intervention_name>
    <description>oral ingestion of placebo containing 20 gram cellulose daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female;&#xD;
&#xD;
          -  18 to 30 years of age;&#xD;
&#xD;
          -  Consuming a vegetarian diet;&#xD;
&#xD;
          -  BMI 20-25 kg/m2.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not meeting all inclusion criteria;&#xD;
&#xD;
          -  Non-vegetarian diet;&#xD;
&#xD;
          -  Excessive alcohol and/or drug abuse;&#xD;
&#xD;
          -  Significant allergies or intolerances concerning the study products;&#xD;
&#xD;
          -  Participation in another biomedical study within 1 month before the first study visit,&#xD;
             possibly interfering with the study results;&#xD;
&#xD;
          -  Medication use known to hamper subject's safety during the study procedures;&#xD;
&#xD;
          -  Subjects with contra-indications for MRI and/or PET-CT;&#xD;
&#xD;
          -  Subjects who do not want to be informed about unexpected medical findings;&#xD;
&#xD;
          -  Subjects who do not want that their treating physician to be informed;&#xD;
&#xD;
          -  Co-morbidities to which the intervention or program that may pose as a complicating&#xD;
             factor;&#xD;
&#xD;
          -  Inability to participate and/or complete the required measurements;&#xD;
&#xD;
          -  PET-CT scan in the last 12 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maastricht University</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 10, 2019</study_first_submitted>
  <study_first_submitted_qc>September 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2019</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University</investigator_affiliation>
    <investigator_full_name>Patrick Schrauwen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Brown adipose tissue</keyword>
  <keyword>Creatine monohydrate</keyword>
  <keyword>Diet-induced thermogenesis</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

